brain cancer

News

Closeup of X-ray photography of human brain

Bayer's regorafenib kicks off brain cancer platform trial

Bayer has become the first pharma company to take part in a new platform trial designed to find new treatments for brain cancer.

News

BMS’ Opdivo fails late-stage brain cancer test

Bristol-Myers Squibb has run into yet another hurdle trying to extend the use of its immuno-oncology blockbuster Opdivo into new types of cancer.

Views & Analysis

An echo through brain cancer’s empty pipeline

Brain tumours kill more people aged under 40 than any other cancer, yet there have been no new treatments for more than a decade. What’s more, there are still none in the pipeline.

News

Certain brain tumours could respond to immunotherapy

Some brain tumours may respond to immunotherapy after all, according to a new study.

Views & Analysis

Kick-starting innovation in Glioblastoma

Can risk-sharing and real-world evidence can provide traction in treating the brain cancer Glioblastoma?

News

x-ray image of human head with brain and electric pulses

Head patch device Optune improves brain cancer survival

Median overall survival improved from 15 months to 21 months when combined with chemotherapy.

Bayer's regorafenib kicks off brain cancer platform trial

BMS’ Opdivo fails late-stage brain cancer test

An echo through brain cancer’s empty pipeline

Certain brain tumours could respond to immunotherapy

Kick-starting innovation in Glioblastoma

Head patch device Optune improves brain cancer survival

Iambic prices its IPO, seeking to raise up to $160m

Discover a new era of healthcare panel engagement: Grounded ...

brain cancer

Editor's Picks